Bausch & Lomb (BLCO): Debt to Book Capitalization Ratio

This price action chart on GURU.Markets illustrates the performance of Bausch + Lomb Corporation (BLCO), whose business relies on a wide range of ophthalmological solutions and medications, ensuring resilience during periods of turbulence. Brand recognition and close ties with medical centers support the company's stability, and the current indicator is 0.85. A commitment to environmental standards is evident in polymer recycling and the sustainable use of water resources.

Investors expect high resilience from Bausch + Lomb Corporation (BLCO), which is supported by the defensive profile of the ophthalmology business and inelastic demand for its products. By analyzing the share of borrowed funds in the firm's balance sheet capitalization, one can assess the dependence of equity on the debt load, where sharp fluctuations in the indicator signal liquidity risks, despite the absence of seasonality in the company's sales.